Evidence map›Paper›PMID 39020287›Full record

ArticleBMC infectious diseases2024

High silent prevalence of human herpesvirus 1 (HSV-1) infection affecting the indigenous reservation of the municipality of Dourados, Central-West Brazil.

Flávia Freitas de Oliveira Bonfim, Livia Melo Villar, Julio Croda, Jéssica Gonçalves Pereira, Ana Carolina Silva Guimarães, Solange Rodrigues da Silva, Crhistinne Cavalheiro Maymone Gonçalves, Lucas Fernando Tinoco Leonardo, Grazielli Rocha de Rezende Romeira, Gabriela Alves Cesar and 6 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Prevalence of herpesvirus, polyomavirus, and respiratory viruses in saliva from a Quilombola community in the Brazilian Amazon.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Flávia Freitas de Oliveira BonfimMolecular Virology and Parasitology Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil.
Livia Melo VillarViral Hepatitis Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil.
Julio CrodaDepartment of Epidemiology of Microbial Diseases, Universidade Federal de Mato Grosso do Sul-UFMS, Campo Grande, Mato Grosso do Sul, Brazil.
Jéssica Gonçalves PereiraMolecular Virology and Parasitology Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil.
Ana Carolina Silva GuimarãesMolecular Virology and Parasitology Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil.
Solange Rodrigues da SilvaBinacional Campus of Oiapoque, Federal University of Amapá, Amapá, 68903419, Brazil.
Crhistinne Cavalheiro Maymone GonçalvesDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Lucas Fernando Tinoco LeonardoLaboratory of Tryposomatid Biology, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil.
Grazielli Rocha de Rezende RomeiraCenter for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande, Grosso do Sul, 79070900, Brazil.
Gabriela Alves CesarCenter for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande, Grosso do Sul, 79070900, Brazil.
Sabrina Weis-TorresCenter for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande, Grosso do Sul, 79070900, Brazil.
Vivianne de Oliveira Landgraf de CastroEnvironmental Analysis Laboratory, Southern Cross University, Military Road East, Lismore, NSW, 2480, Australia.
Marco Aurélio HortaOswaldo Cruz Foundation, Biosafety Level 3 Facility (BSL-3), Rio de Janeiro, 21040360, Brazil.
Simone SimionattoHealth Sciences Research Laboratory, Federal University of Grande Dourados (UFGD), Dourados, Mato Grosso do Sul, Brazil.
Ana Rita Coimbra Motta-CastroCenter for Biological and Health Sciences, Blood Center Sector, Federal University of Mato Grosso do Sul, Campo Grande, Grosso do Sul, 79070900, Brazil.
Vanessa Salete de PaulaMolecular Virology and Parasitology Laboratory, Oswaldo Cruz Foundation, Rio de Janeiro, 21040360, Brazil. vdepaula.fiocruz@gmail.com.

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 440245/2018-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior , Brasil 001Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul 041/2017
6 · The paper itself

Abstract

backgroundThe indigenous population located in the central region of Brazil, is the second largest in terms of population size in the country. The Indigenous Reserve of Dourados has risk factors that increase the vulnerability of the indigenous population to infectious diseases, especially Human alphaherpesvirus (HSV-1), a neglected disease with high prevalence in priority populations in developing countries. The virus can also cause many more severe diseases, including widespread neonatal infections, herpetic keratitis, and herpes encephalitis, which can be fatal if left untreated. We estimated the prevalence of anti-HSV-1 antibodies and correlated it with the demographic and behavioral characteristics of the Indigenous population of the Jaguapirú and Bororó villages (Dourados, Mato Grosso do Sul (MS), Brazil).

methodsOur approach was cross-sectional. From March 2017 to November 2018. Using anti-HSV-1 (Gg1) IgM and anti-HSV-1 (gG1) IgG Euroimmun and the detection and quantification of HSV-1 viral load in plasma samples, through real-time PCR. The maps were constructed using QGIS and the statistical analyses using R Studio software.

resultsA total of 1138 individuals (> 18 years old) were enrolled. The prevalence of anti-HSV-1 IgM and IgG were 20% and 97.5%, respectively. The prevalence of anti-HSV-1 antibodies for IgG was higher in both sexes. Anti-HSV-1 IgM antibodies were present in 17.1%, 21.2%, 12.5%, and 22% of the participants with urinary problems, genital wounds, genital warts, and urethral discharge, respectively. Real-time PCR was used for confirmatory testing; HSV-1 DNA was detected in 25.6% (54/211) of anti-HSV1 IgM-positive samples. Viral loads ranged from 5.99E + 02 to 3.36E + 13.

conclusionsThe seroprevalence of HSV-1 IgM and detection of HSV-1 DNA in the Indigenous population confirmed high silent prevalence. Furthermore, the seroprevalence of HSV-1 in the Indigenous population was higher than that reported in the general adult Brazilian population. Various socioeconomic factors, drug use, and health and sexual behaviors could contribute to the facilitation of HSV-1 transmission in the Indigenous population. Our results may help develop culturally appropriate intervention programs that eliminate health access barriers and improve the implementation of public health policies aimed at promoting information regarding the prevention, treatment, and control of HSV-1 infection in Brazilian Indigenous populations.

Indexed as

Antibodies, ViralHerpes SimplexAdolescentAdultAgedBrazilChildCross-Sectional StudiesFemaleHerpesvirus 1, HumanHumansImmunoglobulin GImmunoglobulin MIndians, South AmericanMaleMiddle AgedAntibodies, ViralImmunoglobulin GImmunoglobulin MBrazilEpidemiologyHuman alphaherpesvirus 1Human herpes virus 1Indigenous

Identifiers

PMID39020287
PMCPMC11253429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.